Braun Stacey Associates Inc. Takes Position in Globe Life Inc. $GL

Braun Stacey Associates Inc. acquired a new position in shares of Globe Life Inc. (NYSE:GL) in the second quarter, Holdings Channel.com reports. The fund acquired 56,462 shares of the company’s stock, valued at approximately $10,089,000.

Other institutional investors have also added to or reduced their stakes in the company. Compound Planning Inc. lifted its stake in Globe Life by 4.3% during the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after purchasing an additional 82 shares during the last quarter. Root Financial Partners LLC increased its position in shares of Globe Life by 23.3% during the 1st quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after purchasing an additional 83 shares during the last quarter. Parallel Advisors LLC raised its holdings in shares of Globe Life by 5.6% during the 4th quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after buying an additional 87 shares in the last quarter. First United Bank & Trust raised its holdings in shares of Globe Life by 2.1% during the 1st quarter. First United Bank & Trust now owns 4,355 shares of the company’s stock valued at $606,000 after buying an additional 90 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Globe Life by 4.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 2,366 shares of the company’s stock valued at $329,000 after buying an additional 91 shares in the last quarter. Institutional investors own 81.61% of the company’s stock.

Globe Life Stock Down 1.3%

Shares of Globe Life stock opened at $173.41 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. The company’s fifty day simple moving average is $178.77 and its two-hundred day simple moving average is $159.53. The company has a market cap of $13.33 billion, a P/E ratio of 11.51 and a beta of 0.48. Globe Life Inc. has a 12-month low of $127.85 and a 12-month high of $191.55.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter last year, the company posted $3.05 earnings per share. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Research analysts anticipate that Globe Life Inc. will post 15.71 EPS for the current year.

Globe Life Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s dividend payout ratio is presently 8.76%.

Globe Life declared that its board has initiated a share repurchase program on Monday, August 10th that permits the company to repurchase $2.50 billion in shares. This repurchase authorization permits the company to reacquire up to 17.7% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s management believes its shares are undervalued.

Analysts Set New Price Targets

GL has been the subject of several research reports. Keefe, Bruyette & Woods cut their target price on Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research note on Friday, July 24th. Weiss Ratings downgraded shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. Jefferies Financial Group boosted their price objective on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a report on Friday, July 10th. Piper Sandler upped their price objective on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Finally, Morgan Stanley increased their target price on shares of Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a report on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $191.67.

Insiders Place Their Bets

In other Globe Life news, CEO Frank M. Svoboda sold 10,000 shares of the firm’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $166.68, for a total value of $1,666,800.00. Following the completion of the sale, the chief executive officer directly owned 54,020 shares in the company, valued at $9,004,053.60. This trade represents a 15.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Cheryl Alston sold 8,258 shares of Globe Life stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the sale, the director directly owned 16,621 shares in the company, valued at approximately $2,979,148.04. The trade was a 33.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 151,908 shares of company stock valued at $27,239,981 over the last ninety days. 2.11% of the stock is owned by corporate insiders.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.